| Date |
Title |
Rating |
| 2009-09-30 |
CBR Pharma reports on M&A in the biopharmaceutical industry |
None |
| 2009-09-30 |
Inspirion Delivery Technologies completes Pre-IND meeting with the FDA |
None |
| 2009-09-30 |
Emergent BioSolutions receives NIAID funding support for dmPA7909 anthrax vaccine candidate |
None |
| 2009-09-30 |
Amicus Therapeutics to initiate Phase 1 study of AT2220 |
None |
| 2009-09-30 |
Caraco enters into a consent decree with the FDA regarding its drug manufacturing operations |
None |
| 2009-09-30 |
FDA approves Mylan Pharmaceuticals' Carbidopa and Levodopa tablets |
None |
| 2009-09-30 |
Sun Pharma Global issues notice to Labopharm regarding its generic versions of Ryzolt |
None |
| 2009-09-30 |
Orphan drug designation for pixantrone applied by Cell Therapeutics |
None |
| 2009-09-30 |
IDRI and Academia Sinica sign Memorandum of Understanding |
None |
| 2009-09-30 |
Mellow Hope granted H1N1 license by SFDA |
5 |
| 2009-09-30 |
FDA's Structured Product Labeling to be discussed |
None |
| 2009-09-30 |
Global outlook series on alternative medicine industry |
None |
| 2009-09-30 |
Non-human primate study results of Restanza released |
None |
| 2009-09-30 |
Reportlinker on key players in the Middle Eastern pharmaceutical market |
None |
| 2009-09-30 |
Report on the Serbian pharmaceutical and healthcare market |
None |
| 2009-09-30 |
Report on the impact of counterfeits on parallel trade & pharmaceutical distribution |
None |
| 2009-09-30 |
Tβ4 therapy in EAE mice improves neurological functional recovery |
None |
| 2009-09-30 |
Sanofi-aventis announces study results comparing efficacy of Lantus to detemir |
5 |
| 2009-09-30 |
SATAI invests $1.045 million in Azaya Therapeutics |
None |
| 2009-09-30 |
New anticoagulant therapy has fewer side-effects than warfarin |
None |
| 2009-09-30 |
Report on India's pharmacy retail market |
None |
| 2009-09-30 |
Burzynski Research Institute and BBSF sign Research Agreement |
None |
| 2009-09-30 |
Also in global health news: Drought in East Africa; improving food processing in Africa; Hajj pilgrims must take polio vaccine; fighting insecticide-resistant mosquitoes |
None |
| 2009-09-30 |
Reuters examines how HIV vaccine trial results will guide future studies |
None |
| 2009-09-30 |
Atrial fibrillation drug pipeline report offered by Research and Markets |
None |
| 2009-09-30 |
Study reveals that most Americans will refuse FDA authorized emergency use H1N1 flu vaccine |
None |
| 2009-09-30 |
Total Wellness ready to meet increased demand for the seasonal flu vaccine |
None |
| 2009-09-30 |
Aetna announces first-dollar coverage for H1N1 flu vaccine administration |
None |
| 2009-09-29 |
Renewed GMP certification for China Biologic Products' Qianfeng subsidiary |
None |
| 2009-09-29 |
Slovenia's pharmaceuticals and healthcare industry report from Research and Markets |
None |
| 2009-09-29 |
90-day supply program to improve overall healthcare |
None |
| 2009-09-29 |
Repros Therapeutics receives further clarification on the Full Clinical Hold status of Proellex |
None |
| 2009-09-29 |
IP Advocate founder to speak on commercialization barriers faced by university faculty inventors |
None |
| 2009-09-29 |
Turkey's pharmaceuticals and healthcare industry report from Research and Markets |
3 |
| 2009-09-29 |
Sciele Pharma files NDA for glycopyrrolate oral solution |
None |
| 2009-09-29 |
Journal publishes Hythiam's PROMETA treatment program results |
None |
| 2009-09-29 |
Oculus launches Microcyn Skin & Wound HydroGel OTC |
None |
| 2009-09-29 |
Report on next generation oncology products |
None |
| 2009-09-29 |
Research And Markets' new report on global diabetes market |
None |
| 2009-09-29 |
Algeria's pharmaceuticals and healthcare industry report |
None |
| 2009-09-29 |
Januvia in combination with metformin or taken alone lowers blood sugar |
2 |
| 2009-09-29 |
Report on Hungary's pharmaceuticals and healthcare industry |
None |
| 2009-09-29 |
AAPS Annual Meeting to discuss new research and technologies in pharmaceutical sciences |
None |
| 2009-09-29 |
BDI Pharma's proprietary flu vaccine supply program SecuriFLU successful |
None |
| 2009-09-29 |
Walk-in flu shots to lure customers into drugstores |
None |
| 2009-09-29 |
New measles vaccination methods to reduce costs and improve safety |
None |
| 2009-09-29 |
Flu shots available at Concentra Urgent Care locations |
3 |
| 2009-09-29 |
Additional countries to join in donating H1N1 vaccines to developing countries, U.N official says |
None |
| 2009-09-28 |
SOHM launches 26 branded generic pharmaceutical products in India |
None |
| 2009-09-28 |
UNC awarded $8.6M for a new Center for Integrated Systems Genetics |
None |
| 2009-09-28 |
MarkMonitor Brandjacking Index reveals growth in pharmaceutical brandjacking for popular drug brands |
None |
| 2009-09-28 |
Merck to distribute Afluria in the U.S. for CSL Biotherapies |
None |
| 2009-09-28 |
European Commission grants conditional marketing authorization for Gilead's Cayston |
None |
| 2009-09-28 |
Safety profiles of JANUVIA and JANUMET drugs established through clinical development program |
2 |
| 2009-09-28 |
Presentations on Inovio Biomedical's electroporation-delivered DNA vaccines |
None |
| 2009-09-28 |
WellPoint covers administration costs for H1N1 vaccines |
None |
| 2009-09-28 |
Merck, Qiagen pledge cervical cancer tools at CGI, meeting highlights effects of gender inequality |
None |
| 2009-09-28 |
France's pharmaceuticals and healthcare industry report |
None |
| 2009-09-28 |
FDA grants accelerated approval for Allos Therapeutics’ FOLOTYN |
None |
| 2009-09-28 |
Quintiles Transnational enter into marketing agreement with Allergan for SANCTURA XR |
None |
| 2009-09-28 |
H1N1 vaccine for limited supply only to people at highest risk |
None |
| 2009-09-28 |
WHO Asia-Pacific Countries pledge to use artemisinin with other drugs by 2015 to prevent drug-resistance |
None |
| 2009-09-27 |
Rosiglitazone slows progression of cachexia in cancer affected mice |
None |
| 2009-09-26 |
Cantwell amendment will raise cost of prescription drugs: PCMA |
None |
| 2009-09-26 |
European CHMP recommends Merck's JANUVIA and JANUMET as add-on to insulin |
3.3 |
| 2009-09-26 |
European CHMP recommends marketing approval for Sanofi-aventis' Multaq |
None |
| 2009-09-26 |
Teva to market generic version of AstraZeneca's antipsychotic agent Seroquel tablets |
None |
| 2009-09-26 |
GenVec to receive $2.3M from NIAID for HIV vaccine candidate production |
None |
| 2009-09-25 |
Stelara approved by the FDA for treating psoriasis |
4 |
| 2009-09-25 |
WHO lowers expectation of H1N1 vaccine output, appeals for donations to fight pandemic |
None |
| 2009-09-25 |
Folotyn approved for the treatment of Peripheral T-Cell Lymphoma |
None |
| 2009-09-25 |
Health officials anticipate 6 million H1N1 vaccine doses by early October |
None |
| 2009-09-25 |
Report on U.S. market for Rx-to-OTC Switches released |
None |
| 2009-09-25 |
Wiley's report on connecting innovations in microbiology and biochemistry to engineering fundamentals |
None |
| 2009-09-25 |
Investigational New Drug application for Uricase-PEG 20 approved |
None |
| 2009-09-25 |
Report on the current market size for U.S. Pharmacodiagnostics |
None |
| 2009-09-25 |
Report on the wound care management market in Asia Pacific region released |
None |
| 2009-09-25 |
Wound Management Technologies inks marketing agreement with Pharma Technology International |
None |
| 2009-09-25 |
Phase III PLATO study proves that ticagrelor is more effective than clopidogrel |
3 |
| 2009-09-25 |
Vertex Pharmaceuticals to present SVR data at the 60th Annual Meeting of the American Association |
None |
| 2009-09-25 |
ACP releases paper promoting increased funding for FDA |
None |
| 2009-09-25 |
Reportlinker offers a new report on the pharmaceutical market in Russia |
None |
| 2009-09-25 |
Report on the global biosimilars market |
None |
| 2009-09-25 |
Research and Markets' report on global ophthalmic pharmaceutical market |
None |
| 2009-09-25 |
New report on the therapeutic markets for stem cells |
None |
| 2009-09-25 |
Changing trends and developments in the global market for vaccines |
None |
| 2009-09-25 |
New market research report on oral drug delivery market |
4 |
| 2009-09-25 |
Compounds of Viagra may counter heart diseases |
None |
| 2009-09-25 |
New report on DNA vaccine market |
None |
| 2009-09-25 |
Phase III clinical trial of investigational HIV vaccine regimen complete |
None |
| 2009-09-25 |
Qrxpharma forms an alliance with Liaoning Nuokang Medicines to commercialise its venomics assets |
3 |
| 2009-09-25 |
Seasonal and H1N1 flu vaccines from Priority Health |
None |
| 2009-09-25 |
Research study supports reovirus and cisplatin combination for cancer treatment |
None |
| 2009-09-25 |
Fomepizole Injection launched by Bioniche Pharma |
None |
| 2009-09-25 |
NDA submitted to the FDA for new osteoarthritis drug |
5 |
| 2009-09-25 |
FDA grants priority review for Cephalon's sNDA |
None |
| 2009-09-25 |
Report on the Indian pharmaceutical market |
None |
| 2009-09-25 |
Investigational vaccine shows modest potential for protecting against HIV infection |
None |
| 2009-09-25 |
Combination drug to limit the dangerous side effects of morphine |
None |
| 2009-09-24 |
Report on the Middle East and Africa pharmaceutical industry |
None |
| 2009-09-24 |
Drug Discovery and Development to focus on pharmaceutical trends |
None |
| 2009-09-24 |
Report on the evolution of the pharmaceutical market |
None |
| 2009-09-24 |
Patents listed in FDA's Orange Book for Eli Lilly’s Evista invalidated |
None |
| 2009-09-24 |
Rio Grande Dermatology offers eyelash drugs for $99 |
None |
| 2009-09-24 |
Flood-affected customers in Georgia can obtain early refills of their prescriptions |
None |
| 2009-09-24 |
Walgreens ensures that all its pharmacies can provide Tamiflu |
None |
| 2009-09-24 |
Octapharma AG submits Biological License Application for its octagam(R) 10% to FDA |
None |
| 2009-09-24 |
Biotech company Pharming Group receives confirmation of validation for Rhucin |
5 |
| 2009-09-24 |
PCMA releases statement regarding the Senate Finance Committee’s ongoing deliberations on health-care reform |
None |
| 2009-09-24 |
Controlled release pills and capsules with dose dumping tendency should be tested |
None |
| 2009-09-24 |
Merck, QIAGEN to collaborate to increase access to HPV vaccination and HPV DNA testing in developing countries |
None |
| 2009-09-24 |
Market research report on Gilead Sciences' product pipeline |
None |
| 2009-09-24 |
New report on CEL-SCI's H1N1 flu drug candidate |
None |
| 2009-09-24 |
Rasagiline slows the rate of Parkinson's disease progression |
None |
| 2009-09-24 |
Update on Cerezyme and Fabrazyme supply from Genzyme Corporation |
None |
| 2009-09-24 |
It is possible to reduce the risk of HIV infection with a vaccine: AVAC |
None |
| 2009-09-24 |
New market research report focuses on Forest Laboratories' product pipeline |
None |
| 2009-09-24 |
Court rules in favor of Eli Lilly for Evista's method-of-use patents |
None |
| 2009-09-24 |
Enrollment for pSivida's pilot FAVOR clinical study commences |
None |
| 2009-09-24 |
ADAGIO clinical trial results demonstrating AZILECT's efficacy published |
None |
| 2009-09-24 |
Acetaminophen can prevent age-related problems |
None |
| 2009-09-24 |
VisEn launches new imaging agent for monitoring key hypertension and renal disease biomarker |
None |
| 2009-09-24 |
Z-Medica launches the QuikClot Interventional hemostatic bandage for use during catheterization procedures |
None |
| 2009-09-23 |
Safety tips for OTC and prescription medications |
None |
| 2009-09-23 |
Four percent annual growth for chronic pain drug market |
None |
| 2009-09-23 |
Frost & Sullivan: Multi-client study to analyze roles and responsibilities of pharmacists and pharmacies in U.S. |
None |
| 2009-09-23 |
Adolor acquires exclusive worldwide rights to OpRA III |
None |
| 2009-09-23 |
New drug test promises to yield quick and effective response for cancer therapy |
None |
| 2009-09-23 |
Second annual study of FDA drug review released |
None |
| 2009-09-23 |
Bioelectronics files for pre-marketing clearance for its ActiPatch® Therapy products |
5 |
| 2009-09-23 |
Top 20 pharma companies seek out new partnering opportunities at BIO-Europe 2009 |
1 |
| 2009-09-23 |
UBC acquires Gigamoto Technology Partners to implement risk management programs |
5 |
| 2009-09-23 |
Preclinical data on Protalix Biotherapeutics' antiTNF released |
None |
| 2009-09-23 |
EGFR-targeted therapy improves survival rates in metastatic colorectal cancer patients |
None |
| 2009-09-23 |
FDA committees to review Neuromed’s NDA for Exalgo |
None |
| 2009-09-23 |
Results of IES presented at ECCO |
None |
| 2009-09-23 |
Update from Advanced Cell on pre-clinical activities for its RPE cell program |
None |
| 2009-09-23 |
Chan calls for additional H1N1 vaccines for poor countries during WHO Asia-Pacific regional meeting |
None |
| 2009-09-23 |
Government orders additional H1N1 vaccine |
None |
| 2009-09-22 |
Sanofi Pasteur receives additional order H1N1 vaccine |
None |
| 2009-09-22 |
China SFDA awards Jiangsu Yanshen a new drug certificate and production license for its H1N1 vaccine |
None |
| 2009-09-22 |
Emissary Capital begins investment research coverage on Sinobiopharma |
None |
| 2009-09-22 |
Gerresheimer opens new R&D and production centers in USA and Europe |
None |
| 2009-09-22 |
Drug registration process for Nutra Pharma's pain reliever begins |
None |
| 2009-09-22 |
FemSoft from Rochester Medical included in the UK Drug Tariff |
None |
| 2009-09-22 |
Gerresheimer opens new R&D and production centers in USA and Europe |
None |
| 2009-09-22 |
CSL Behring offers new dosage strength of Helixate FS in U.S. |
None |
| 2009-09-22 |
PeriGen’s protocol bundle to prevent H1N1 in pregnant women |
None |
| 2009-09-22 |
Rexahn and Teva sign license and stock purchase agreements |
None |
| 2009-09-22 |
U.S. HHS orders for an additional 29 million doses of MedImmune's influenza vaccine |
None |
| 2009-09-22 |
Investigative drug hampers the survival of non-Hodgkin lymphoma cells |
None |
| 2009-09-22 |
GeoVax requests FDA meeting to discuss IND for its therapeutic HIV/AIDS vaccine |
None |
| 2009-09-22 |
Lundbeck offers Sabril for treating children with infantile spasms in the U.S. |
5 |
| 2009-09-22 |
Coenzyme Q10 to slow down the effects of Parkinson's disease? |
None |
| 2009-09-22 |
Congress urged to delay pending Medicaid cuts |
None |
| 2009-09-22 |
Dalton Pharma expands pharmaceutical manufacturing services |
None |
| 2009-09-21 |
Nanoviricides and Southern Research sign agreement to test anti-Influenza and anti-HIV drug candidates |
None |
| 2009-09-21 |
U.S. Department of Health & Human Services requests BioCryst for proposal for peramivir supply |
None |
| 2009-09-21 |
ICF International awarded over $7M to effectively communicate substance abuse prevention |
None |
| 2009-09-21 |
King Pharmaceuticals achieves milestone: Announces commercial availability of EMBEDA |
None |
| 2009-09-21 |
Impax Laboratories challenges Galderma Laboratories' patents |
None |
| 2009-09-21 |
NIAID awards DOR BioPharma a $9M grant to develop thermostable and rapidly acting vaccines |
None |
| 2009-09-21 |
Report on clinical advances in personalized medicine |
None |
| 2009-09-21 |
AstraZeneca and Nektar Therapeutics enter worldwide license agreement for two drug development programmes |
None |
| 2009-09-21 |
The 2009 National Pharmacy Study ranks Prescription Solutions second among mail order pharmacies |
None |
| 2009-09-21 |
Emerging trends in the evolving Pharma M&A landscape |
None |
| 2009-09-21 |
Ipsen's Azzalure muscle relaxant receives Spanish AEMPS marketing approval |
1 |
| 2009-09-21 |
Report on the global ophthalmic pharmaceutical market |
None |
| 2009-09-21 |
Kenya to launch measles vaccine campaign |
None |
| 2009-09-21 |
Iodinated, Gadolinium based contrast agents do not negatively affect patients |
None |
| 2009-09-21 |
Abbott Prism HIV O Plus assay approved by FDA |
None |
| 2009-09-21 |
New interferon/lovastatin treatment to battle cancer |
None |
| 2009-09-19 |
CEO of pSivida to discuss new technologies in retinal drug delivery at the San Diego Ophthalmic summit |
None |
| 2009-09-19 |
PCMA statements on mail-service pharmacies |
None |
| 2009-09-19 |
Quidel's updates information on its Influenza A+B test package insert |
None |
| 2009-09-19 |
Report on design of drugs targeting zinc enzymes |
None |
| 2009-09-19 |
Competitive Intelligence Report on epidermal growth factor receptor agonists and antagonists |
None |
| 2009-09-19 |
Report on molecular pathology tools for drug development |
None |
| 2009-09-19 |
Pfizer Oncology to present early-stage research of investigational agents for cancer treatment |
None |
| 2009-09-19 |
Report on benefit-risk assessment in medicine |
None |
| 2009-09-19 |
New ultra-thin adhesives introduced by Avery Dennison Specialty Tape Division |
None |
| 2009-09-18 |
EPO and growth factor therapy safe for anemic MDS patients |
None |
| 2009-09-18 |
'Spice' drugs easily available for youngsters |
None |
| 2009-09-18 |
Researchers to develop a safer and synthetic alternative to current heparin |
None |
| 2009-09-18 |
Metabolic Research to participate in the Olympia Expo |
None |
| 2009-09-18 |
Report on the generics market in CEE and Latin America released |
None |
| 2009-09-18 |
MemoryXL improves cognitive performance in Alzheimer's disease |
None |
| 2009-09-18 |
New vaccine may prove effective against urinary tract infections |
3 |
| 2009-09-18 |
Partnership between Wellcome Trust and Merck & Co |
None |
| 2009-09-18 |
New report on Chinese asthma drug market |
5 |
| 2009-09-18 |
Phase I trial of NPC-1C to commence |
None |
| 2009-09-18 |
Juvaris BioTherapeutics completes first close on Series B equity financing |
None |
| 2009-09-18 |
Rexahn to sign licensing and stock purchase agreements with Teva Pharmaceutical |
None |
| 2009-09-18 |
Griffin Securities' report features stem cell hypothesis of cancer |
None |
| 2009-09-18 |
FDA approves Valturna tablets for treating high blood pressure |
None |
| 2009-09-18 |
HPN-100 drug receives orphan product designation |
None |
| 2009-09-18 |
FDA advises consumers not to use stolen respiratory medications |
None |
| 2009-09-18 |
Mayo Clinic scientists conduct clinical study on functional dyspesia patients |
None |
| 2009-09-18 |
Vitamin K prevents age-related conditions |
3 |
| 2009-09-18 |
WHO in talks with developed countries about sharing H1N1 vaccine with developing nations |
None |
| 2009-09-18 |
Drugs industry names the contraceptive pill as the greatest pharmacy innovation of the past 150 years |
None |
| 2009-09-18 |
Preventive treatment extension after kidney transplantation reduces the risk of CMV disease |
None |
| 2009-09-18 |
HTDS update on its H1N1 project status |
None |
| 2009-09-18 |
Biomaterial gel for treating spinal cord injury |
None |
| 2009-09-18 |
Merck, Wellcome Trust to launch vaccine center in India to produce vaccines for developing countries |
None |
| 2009-09-17 |
Quidel's QuickVue Influenza A+B test receives special 510(k) clearance for H1N1 reactivity update |
None |
| 2009-09-17 |
A not-for-profit mission from Wellcome Trust and Merck to develop affordable vaccines for low-income countries |
None |
| 2009-09-17 |
Nimotuzumab drug approved for Mexican distribution |
None |
| 2009-09-17 |
FDA: Manufacturers to include warning of promethazine hydrochloride injection on labels |
None |
| 2009-09-17 |
LAB Research signs exclusive agreement to extend Korean market |
None |
| 2009-09-17 |
Report on Polyphosphazenes for Biomedical Applications |
None |
| 2009-09-17 |
DDI Predict 2009 edition assessing the risk of potential drug-drug interactions released |
None |
| 2009-09-17 |
Report highlights the link between the latest chemical biology approaches and novel drug therapies |
None |
| 2009-09-17 |
GENova Biotherapeutics signs collaboration deal with Beckpharma |
None |
| 2009-09-17 |
Glaxo conceals risks: Antidepressant drug Paxil causes birth defects |
None |
| 2009-09-17 |
Cepacol introduces instant pain relief tablets for children with sore throats |
None |
| 2009-09-17 |
BioMedReports.Com's news report on CEL-SCI's key developments |
None |
| 2009-09-17 |
NCPA happy with Baucus' proposals for community pharmacies |
None |
| 2009-09-17 |
Report on the design of peptides and proteins for biopharmaceutical applications |
None |
| 2009-09-17 |
Research and Markets' report on novel approaches to pain management |
None |
| 2009-09-17 |
Mechanism of action of the anti-cancer drug GMX1778 identified |
None |
| 2009-09-17 |
Report on growth in the European STM information market |
None |
| 2009-09-17 |
Findings may lead to drugs that destroy TB in dormant stage of lifecycle |
None |
| 2009-09-17 |
China allergy drug market report from Research and Markets |
None |
| 2009-09-17 |
FDA issues a complete response letter for Sanofi-aventis' eplivanserin NDA |
None |
| 2009-09-17 |
Weis Markets to hold low-cost flu shot program |
None |
| 2009-09-17 |
DNage's observational study assesses natural progression of CS in children |
None |
| 2009-09-17 |
IPTi tool with SP medicine helps prevent malaria in African infants |
5 |
| 2009-09-17 |
APP Pharmaceuticals announces FDA marketing approval of Deferoxamine Mesylate |
None |
| 2009-09-17 |
Study: Therapy addition reduces risk of stroke and other cardiovascular events |
None |
| 2009-09-17 |
Genentech releases Phase III PRIMA study findings |
None |
| 2009-09-17 |
Fully-insured members of Capital BlueCross to receive coverage for administration fee for H1N1 Flu vaccine |
None |
| 2009-09-17 |
GENova to sign extensive collaboration agreement with Beckpharma |
None |
| 2009-09-17 |
FDA approves Sirion's Zirgan for treating acute herpetic keratitis |
None |
| 2009-09-17 |
FDA Advisory Committee recommends marketing approval for Auxilium's XIAFLEX to treat Dupuytren's contracture |
None |
| 2009-09-17 |
Administrative cost of H1N1 vaccine to be covered for CIGNA's customers |
None |
| 2009-09-17 |
BioSpecifics Technologies' XIAFLEX receives marketing approval from FDA |
None |
| 2009-09-16 |
OCLS' partnership with V&M Industries to market Microcyn-based skin and wound care products |
None |
| 2009-09-16 |
Keryx Biopharmaceuticals receives orphan-drug designation for a multiple myeloma drug |
None |
| 2009-09-16 |
Matrix Laboratories receives tentative FDA approval for its NDA |
None |
| 2009-09-16 |
KemPharm announces nomination of its second pipeline candidate |
5 |
| 2009-09-16 |
Inovio’s novel platform for developing DNA based vaccines to be discussed at EmTech |
None |
| 2009-09-16 |
Santaris Pharma establishes its operations in the U.S. |
None |
| 2009-09-16 |
Precise T cell correlates of protection need to be identified for vaccine design |
None |
| 2009-09-16 |
RXi Pharmaceuticals to present in vivo data of rxRNA compounds |
None |
| 2009-09-16 |
Six research project grants aimed at improving human health awarded |
None |
| 2009-09-16 |
Report on the U.S. Pharmaceutical Preparation Manufacturing Industry |
None |
| 2009-09-16 |
LEAD Therapeutics' LT-29 antibiotic effective against most common antibiotic resistant bacteria |
None |
| 2009-09-16 |
New market research report on Chinese Avermectin Industry |
None |
| 2009-09-16 |
PhotoMedex unveils Neova DNA Repair Factor Nourishing Lotion |
None |
| 2009-09-16 |
FDA approves sBLA for Influenza A (H1N1) 2009 Monovalent Vaccine |
None |
| 2009-09-16 |
BioMedReports.Com issues special investigative report on CEL-SCI |
None |
| 2009-09-16 |
Clinical trial data of Lipsovir presented at ICAAC |
None |
| 2009-09-16 |
AMRI files two new patent infringement lawsuits |
None |
| 2009-09-16 |
Study reveals ineffectiveness of insulin and metformin against inflammatory biomarkers |
None |
| 2009-09-16 |
Urgent vaccine requirements for treating epidemic diseases voiced at ECI 2009 |
None |
| 2009-09-16 |
Ganeden Biotech unveils the first quick dissolving, thin strip probiotic product |
None |
| 2009-09-16 |
GENova Biotherapeutics and Prime BioResearch sign collaboration agreement |
None |
| 2009-09-16 |
FDA grants orphan drug status to Advanced Life Sciences' Restanza |
None |
| 2009-09-16 |
New book on pharmacology launched |
None |
| 2009-09-16 |
Bavarian Nordic to deliver IMVAMUNE(R) vaccines |
None |
| 2009-09-16 |
Four H1N1 vaccines approved by FDA |
None |
| 2009-09-16 |
Pre-clinical studies of ID-12 orally-bioavailable inhibitor completes |
None |
| 2009-09-16 |
New peptide-based cancer vaccine tested in genital cancer patients |
None |
| 2009-09-15 |
Phase 3 clinical study results of bazedoxifene released |
None |
| 2009-09-15 |
Idera Pharmaceuticals to discuss TLR-targeted drug discovery and development programs |
None |
| 2009-09-15 |
Biocryst signs agreement with three partners to represent its anti-viral peramivir outside U.S. |
None |
| 2009-09-15 |
Halozyme Therapeutics to present its product development pipeline |
None |
| 2009-09-15 |
Neuroskin Psoriasis Relief DRTV test results announced by avVaa World Health Care |
None |
| 2009-09-15 |
CPEX Pharmaceuticals to discuss the clinical aspects of nasal insulin therapy |
None |
| 2009-09-15 |
Report on the pneumonia drug pipeline from Life Science Analytics |
None |
| 2009-09-15 |
HUYA Bioscience signs first-look agreement with Chinese Academy of Sciences' GIBH |
None |
| 2009-09-15 |
GlaxoSmithKline's Votrient will take significant market share away from Pfizer's Sutent by 2018 |
None |
| 2009-09-15 |
A.P. Pharma and Merial sign license and development agreement for a long-acting pain management product |
None |
| 2009-09-15 |
FluCide more effective than Tamiflu |
None |
| 2009-09-15 |
Forest Laboratories places Armour Thyroid medication on back order |
4.8 |
| 2009-09-15 |
Wake Pharma to present clinical evidence in the treatment of wounds using Wound-Be-Gone at SAWC |
None |
| 2009-09-15 |
Pieris AG and Allergan sign collaboration agreement |
None |
| 2009-09-15 |
MSD's ISENTRESS approved by the EU Commission for treating HIV-1 infection in adult patients |
None |
| 2009-09-15 |
Antibiotics sold online without prescriptions, according to MUSC researchers |
None |
| 2009-09-15 |
Anti-fungal pill found to be effective for treating oral candidiasis |
5 |
| 2009-09-15 |
New operating model for speed delivery of innovative medicines |
None |
| 2009-09-15 |
Oil-and-water-based nanoemulsion could be more effective for treating burns |
None |
| 2009-09-15 |
Cell Therapeutics submits Pediatric Investigation Plan to EMEA for pixantrone |
None |
| 2009-09-15 |
CFAR to host AIDS Vaccine 2010 conferrence |
None |
| 2009-09-15 |
Environmental Solutions International introduces unique, alcohol-free, moisturizing hand sanitizers |
None |
| 2009-09-15 |
Mellow Hope completes clinical trial of H1N1 vaccine, receives approval from SFDA |
None |
| 2009-09-15 |
AzaSite production increased to combat erythromycin ophthalmic ointment shortage |
None |
| 2009-09-15 |
IBC offers coverage for H1N1 and seasonal flu vaccines |
None |
| 2009-09-15 |
Nebulized interferon-gamma helps minimize transmissibility of TB |
None |
| 2009-09-15 |
Sigma-Aldrich to distribute BioLife's HypoThermosol and CryoStor biopreservation media products |
None |
| 2009-09-14 |
New report on the challenges and opportunities in emerging drug formulation technologies |
None |
| 2009-09-14 |
Virtual Pharma Rep - an electronic "go green" revolutionary pharmaceutical sales product |
None |
| 2009-09-14 |
B. Braun Medical to showcase its Prontosan Wound Irrigation Solution at the SAWC Fall Event |
3 |
| 2009-09-14 |
Early vaccination minimizes the risk of damage by potentially harmful infections |
None |
| 2009-09-14 |
Snapdata's report on the Canadian pharmaceutical market |
None |
| 2009-09-14 |
Research and Markets' Snapshots report on the UK OTC pharmaceutical market |
None |
| 2009-09-14 |
CDI and VivoMedica launch pharmaceutical industry consortium |
None |
| 2009-09-14 |
Patient enrollment for Phase 3 clinical trials of VEGF Trap-Eye completed |
None |
| 2009-09-14 |
VBI's flu vaccine offers protection against H1N1 |
None |
| 2009-09-14 |
Mylan Pharmaceutical's ANDA for Teva's Copaxone accepted by FDA (Correction) |
None |
| 2009-09-14 |
Study of the global Kappa-carrageenan market |
None |
| 2009-09-14 |
Pharma CI Conference to focus on pharma industry news and challenges |
None |
| 2009-09-14 |
Trabedersen granted orphan drug designation from both FDA And EMEA for treating pancreatic carcinoma |
5 |
| 2009-09-14 |
Therapeutic Protein market examined |
None |
| 2009-09-14 |
Influenza patients treated with Tamiflu has higher survival rates |
None |
| 2009-09-14 |
Quest Diagnostics' OVA1 ovarian cancer test cleared by the FDA |
4 |
| 2009-09-14 |
New Laurocapram market research report from Research and Markets |
None |
| 2009-09-14 |
FDA approves Theravance's VIBATIV for treating complicated skin and skin structure infections |
None |
| 2009-09-14 |
Clinical study results of DAS181 against H1N1 influenza presented |
None |
| 2009-09-14 |
Laquinimod study data reveals its neuroprotective and anti-inflammatory properties |
None |
| 2009-09-14 |
Review of current diagnosis strategies and treatment options |
None |
| 2009-09-14 |
Naproxcinod clinical study results presented at the 2009 World Congress on Osteoarthritis |
None |
| 2009-09-14 |
Sanofi-aventis and Regeneron Pharmaceuticals discontinue Phase 3 trial of aflibercept |
None |
| 2009-09-14 |
First FOSAMAX case declared as mistrial by the U.S.District Court Judge |
None |
| 2009-09-14 |
Results further support the benefits of TYSABRI for multiple sclerosis patients |
4 |
| 2009-09-14 |
Scabies drug pipeline report from Research and Markets |
1 |
| 2009-09-14 |
Reme-Flu secured as trade name for Nuvilex's homeopathic flu remedy |
None |
| 2009-09-14 |
Research and Markets' report on the ischemia drug pipeline |
None |
| 2009-09-14 |
Mellow Hope completes MEVAC-A tender for Bangladesh |
None |
| 2009-09-14 |
Myasthenia gravis therapy report from Research and Markets |
None |
| 2009-09-14 |
FDA releases latest listing of consumer health information updates |
None |
| 2009-09-14 |
TCAD therapy shows potency against seasonal and novel H1N1 influenza viruses |
None |
| 2009-09-14 |
FAB Pharma to develop new class of anti-MRSA drugs |
None |
| 2009-09-14 |
New report on the prostate cancer drug pipeline |
None |
| 2009-09-14 |
Marketing study conducted to investigate decline in Gardasil vaccine supply |
None |
| 2009-09-11 |
Signum Biosciences awarded $1.6 million SBIR Phase II grant |
None |
| 2009-09-11 |
IRIN examines report on varying cost of ARVs for countries with similar socioeconomic status |
None |
| 2009-09-11 |
FDA accepts Merz Pharmaceuticals' premarket approval application for Belotero Balance |
None |
| 2009-09-11 |
Flu Clinic Locator makes it easy for people to locate the most convenient clinic to get their seasonal flu vaccine |
None |
| 2009-09-11 |
Bioneutral's broad spectrum antimicrobial eradicates the H1N1 swine flu virus |
None |
| 2009-09-11 |
Federal court's approval clears the way for pricing rollback of pharmaceutical drugs |
None |
| 2009-09-11 |
Oculus Innovative Sciences Receives Medicare HCPCS Code For Reimbursement Of Microcyn® Skin & Wound Hydrogel |
None |
| 2009-09-11 |
YuYeQingHuo OTC capsules to treat throat inflammation launched by American Oriental Bioengineering |
None |
| 2009-09-11 |
Accupac to manufacture Access Pharmaceuticals' MuGard |
None |
| 2009-09-11 |
HIV/AIDS patients in U.S. have no long-term treatment options: ATAC report card |
None |
| 2009-09-11 |
Results from a preclinical study of Variation's influenza vaccine to be presented at ICAAC meeting |
None |
| 2009-09-11 |
U.S. Secretary Kathleen Sebelius to participate in a vaccination exercise on the anniversary of 9/11 |
None |
| 2009-09-11 |
Abstracts on Merck Serono oncology treatments to be presented at ECCO and ESMO |
None |
| 2009-09-11 |
PCMA stresses on improving affordability in the health care system |
None |
| 2009-09-11 |
New report on the global biomarker tools and services market |
None |
| 2009-09-11 |
Cymbalta maintains reduction in pain for patients with chronic low back pain |
1 |
| 2009-09-11 |
Tetraphase to present its study on novel classes of antibiotics to treat drug-resistant infections |
None |
| 2009-09-11 |
Update on Prolindac clinical development plan provided by Access Pharmaceuticals |
None |
| 2009-09-11 |
The 2009 report on the global market for Squalane |
None |
| 2009-09-11 |
Amylin and Biocon collaborate to develop a peptide therapeutic for treating diabetes |
None |
| 2009-09-11 |
Study of the global market for Botulinum Toxin |
None |
| 2009-09-11 |
US and European radiopharmaceuticals market report |
None |
| 2009-09-11 |
Recession hits some biopharmaceutical companies and CROs |
None |
| 2009-09-11 |
Memory impairment drug pipeline report from Research and Markets |
None |
| 2009-09-11 |
Bronchospasm drug pipeline report from Research and Markets |
None |
| 2009-09-11 |
Phase 3 trial of ataluren commences |
None |
| 2009-09-11 |
Research and Markets' new report on the diphtheria drug pipeline |
None |
| 2009-09-11 |
Drug manufacturers are seeking out needle-free systems |
None |
| 2009-09-11 |
Neurologists recommend oral cladribine for treating multiple sclerosis |
None |
| 2009-09-11 |
Phase II clinical trial of TAK-700 for treating advanced prostate cancer commences |
None |
| 2009-09-11 |
Efficacy of Instanyl in management of breakthrough cancer pain demonstrated |
None |
| 2009-09-11 |
New market research report on autoimmune disorder treatment |
None |
| 2009-09-11 |
Adamis Pharmaceuticals' Epinephrine injection categorized as a generic |
None |
| 2009-09-11 |
Ascent Therapeutics demonstrates Pepducin efficacy |
None |
| 2009-09-11 |
New report on the chronic obstructive pulmonary disease drug pipeline |
None |
| 2009-09-11 |
Zevalin radioimmunotherapy drug approved for treating non-Hodgkin's lymphoma |
None |
| 2009-09-11 |
Market research report on the diabetic neuropathy drug pipeline |
None |
| 2009-09-11 |
Abbreviated New Drug Application for nateglinide tablets approved |
None |
| 2009-09-11 |
Nuvilex and Legacy Biotechnologies to develop natural remedies for flu- type symptoms |
5 |
| 2009-09-11 |
Reportlinker's report on anti-obesity drugs |
None |
| 2009-09-11 |
New Drug Application for trabectedin approved by the FDA |
None |
| 2009-09-10 |
Phase 2b clinical trial results of TC-5214 to be presented at nAChR2009 |
None |
| 2009-09-10 |
FDA approves Supplemental New Drug Application for DOXIL |
None |
| 2009-09-10 |
FDA removes clinical hold on HEPLISAV hepatitis B vaccine |
None |
| 2009-09-10 |
Hypercholesterolemia therapy area pipeline report from Research and Markets |
None |
| 2009-09-10 |
Phase Forward's Empirica Suite to be showcased at the 3rd annual conference |
None |
| 2009-09-10 |
METOZOLV drug approved for treating gastroesophageal reflux disease |
None |
| 2009-09-10 |
Inspire Pharmaceuticals to increase production of azithromycin ophthalmic solution |
None |
| 2009-09-10 |
Report on the amyotrophic lateral sclerosis drug pipeline |
None |
| 2009-09-10 |
IBM study reveals the need for smart drug manufacturer supply chain systems |
None |
| 2009-09-10 |
Labopharm to present its novel trazodone formulation data |
None |
| 2009-09-10 |
Report on inflammatory bowel disease drug pipeline |
None |
| 2009-09-10 |
Ketamine shows rapid antidepressant effects |
None |
| 2009-09-10 |
TI Pharma: A role model of public-private cooperation and partnership |
5 |
| 2009-09-10 |
Efficacy of Ore Pharmaceuticals' lead drug candidate discussed |
None |
| 2009-09-10 |
Research and Markets insight into the pipeline status of asthma drugs |
None |
| 2009-09-10 |
Physicians and patients underestimate promotional volume of Actonel |
None |
| 2009-09-10 |
New market research report on the eye infections drug pipeline |
None |
| 2009-09-10 |
Research and Markets' new report on central nervous system drugs |
None |
| 2009-09-10 |
Polio vaccination resumes in Pakistan's Swat Valley |
None |
| 2009-09-10 |
Therapeutic principles of monoclonal antibodies |
None |
| 2009-09-10 |
Biovista's BVA-201 drug for MS shows positive results |
None |
| 2009-09-10 |
New report on the congestive heart failure drug pipeline |
None |
| 2009-09-10 |
Oral GLP-1 Analog approved for human clinical trial |
None |
| 2009-09-10 |
New study highlights the competitive nature of drug development |
None |
| 2009-09-10 |
Clinical trial reveals RENOVA topical treatment cream shows continuous improvement |
None |
| 2009-09-10 |
Research and Markets' report on the growth hormone deficiency drug pipeline |
None |
| 2009-09-10 |
GlaxoSmithKline's CERVARIX receives favorable recommendation from FDA Advisory Committee |
None |
| 2009-09-10 |
First trial of 2009 H1N1 influenza vaccine testing launched |
5 |
| 2009-09-10 |
Clinical study investigates laboratory and clinical implications of proton pump inhibitor drugs |
None |
| 2009-09-10 |
Merck's GARDASIL receives approval from FDA Advisory Committee |
5 |
| 2009-09-09 |
ARUP Laboratories' scientist receives grant to research HIV therapies |
None |
| 2009-09-09 |
Chemgenex completes NDA submission for its omacetaxine mepesuccinate to the FDA |
None |
| 2009-09-09 |
Caldolor launched ahead of schedule in U.S. by Cumberland Pharmaceuticals |
None |
| 2009-09-09 |
HCV treatment study reveals low relapse rate of Pegetron |
None |
| 2009-09-09 |
Updated third-quarter 2009 report on the Belarus pharmaceuticals and healthcare industry |
None |
| 2009-09-09 |
Inspire Pharmaceuticals wins award for its denufosol tetrasodium program |
None |
| 2009-09-09 |
Lawsuit charged against Pfizer for illegal marketing of Geodon |
5 |
| 2009-09-09 |
Presidio Pharmaceuticals' drug development activities to be presented |
None |
| 2009-09-09 |
AOLS to initiate clinical study for testing the efficacy of AEOL 10150 |
None |
| 2009-09-09 |
Ceragenix awarded $2.87M NIH grant to develop a drug for treating Clostrdium difficile and Shigella |
None |
| 2009-09-09 |
Life Science Analytics offers a new report on the Type II diabetes drug pipeline |
None |
| 2009-09-09 |
GENova Biotherapeutics discusses its anti-cancer drug development strategy |
None |
| 2009-09-09 |
Report on the U.S. pharmaceuticals and healthcare industry |
None |
| 2009-09-09 |
The Lithuania Pharmaceuticals and Healthcare Report released by Research and Markets |
None |
| 2009-09-09 |
The 2009 global market for influenza vaccines, therapeutics, and diagnostics |
None |
| 2009-09-09 |
Research and Markets' report on Her2 receptor antagonists for treating cancer |
None |
| 2009-09-09 |
Three government trusts in Arizona sign contract with Navitus Health Solutions |
None |
| 2009-09-09 |
Bayer submits an IND for its MN-IC antibody-drug conjugate to the FDA |
None |
| 2009-09-09 |
Report on prescription drugs in worldwide markets |
None |
| 2009-09-09 |
Maxim Health to launch its annual influenza vaccination program on October 1 |
None |
| 2009-09-09 |
Analysis of nanomedicine in global market |
None |
| 2009-09-09 |
PacifiCord and Milkalicious to sponsor a debate on pediatric vaccines |
None |
| 2009-09-09 |
FDA approves Salix' METOZOLV ODT for treating diabetic gastroparesis |
None |
| 2009-09-09 |
Report analysis on global market of small molecule kinase inhibitors |
None |
| 2009-09-09 |
Gabapentin improves sleep quality in menopausal women |
4.3 |
| 2009-09-09 |
Laureate Pharma and Neoprobe sign manufacturing agreement |
None |
| 2009-09-09 |
BioElectronics to file for FDA pre-marketing clearance of its ActiPatch Therapy product |
5 |
| 2009-09-09 |
Sinovac's first lot of H1N1 vaccine released by China's NICPBP |
None |
| 2009-09-09 |
Care-Tech Laboratories consents to end illegal manufacture and marketing of OTC drugs |
5 |
| 2009-09-09 |
Rice researchers describe a new method to predict the efficacy of H1N1 vaccines |
None |
| 2009-09-09 |
Meda launches EDLUAR in the U.S. |
None |
| 2009-09-09 |
Space-age technology to combat counterfeit pharmaceuticals |
None |
| 2009-09-09 |
China Sky's Pain Relief patches enters Canadian market |
None |
| 2009-09-09 |
Teva Pharmaceutical Industries to present MS treatment research data |
None |
| 2009-09-09 |
NIH awards Vaxart $2.8M grant to develop an orally-delivered H5N1 Avian influenza vaccine |
None |
| 2009-09-09 |
GENova Biotherapeutics files patent for Prostaganin anti-cancer drug |
3 |
| 2009-09-09 |
FDA approves ISTA's Bepreve for treating ocular itch |
None |
| 2009-09-08 |
Report on the pharmaceutical market in Brazil, Russia, India & China |
None |
| 2009-09-08 |
Reportlinker's new market research report on excipients market |
None |
| 2009-09-08 |
Cytrx to submit revised protocol for arimoclomol Phase IIb clinical trial |
None |
| 2009-09-08 |
KRYSTEXXA development and treatment failure gout to be presented |
None |
| 2009-09-08 |
FDA undecided on safety guidelines for hydroquinone use |
None |
| 2009-09-08 |
Opexa Therapeutics' ongoing development program for Tovaxin to be presented |
None |
| 2009-09-08 |
Research and Markets offers a new report on the alopecia therapy area pipeline |
None |
| 2009-09-08 |
Research and Markets releases report on cough drug pipeline information |
None |
| 2009-09-08 |
Report on the irritable bowel syndrome drug pipeline from Life Science Analytics |
None |
| 2009-09-08 |
Protalix receives orphan drug designation for prGCD |
None |
| 2009-09-08 |
Shire's assistance helps Gaucher patients manage imiglucerase supply shortage |
None |
| 2009-09-08 |
NanoViricides' drug pipeline to be discussed at NanoBusiness2009 |
None |
| 2009-09-08 |
Research and Markets' report on malaria drug pipeline |
None |
| 2009-09-08 |
Report on multinational and domestic strategies in emerging markets |
None |
| 2009-09-08 |
Pharma manufacturer's failure to disclose endangers Swine Flu vaccination program |
5 |
| 2009-09-08 |
Impact Fusion International completes geographic market test of Intact Digest |
None |
| 2009-09-08 |
Pronova BioPharma receives the 2009 Frost & Sullivan Excellence in Financial & Risk Management Award |
None |
| 2009-09-08 |
New technology developed to detect counterfeit drugs |
None |
| 2009-09-08 |
Azelastine and fluticasone combination for allergic rhinitis gets new lease |
None |
| 2009-09-08 |
Report on the Chilean pharmaceutical market from Research and Markets |
None |
| 2009-09-08 |
COPD patients to have better protection against pneumonia with new vaccine |
None |
| 2009-09-07 |
Insects can be used to test the efficiency of new drugs |
5 |
| 2009-09-07 |
Reversible cell-specific drug delivery with aptamer-functionalized liposomes |
None |
| 2009-09-07 |
Regurin XL capsule for the treatment of OAB launched in UK |
None |
| 2009-09-07 |
Identifying a specific molecular signature can help customize cancer treatment |
None |
| 2009-09-07 |
Ipsen grants license to Debiopharm for developing and commercialising cancer treatment |
None |
| 2009-09-07 |
Biotechnological approach to fight H1N1 influenza |
3 |
| 2009-09-07 |
Debiopharm granted license to develop and commercialise CDC25 |
None |
| 2009-09-07 |
Bacterium's S-layer secretes many therapeutic proteins |
5 |
| 2009-09-07 |
Cancer drug could restore memory deficits in Alzheimer's patients |
None |
| 2009-09-05 |
Opinion: Local drug production in developing countries; Obama's PEPFAR changes |
None |
| 2009-09-05 |
European MAA for lubiprostone withdrawn by Sucampo Pharma Europe |
None |
| 2009-09-05 |
New report on VEGF and VEGF-R agonists and antagonists |
None |
| 2009-09-05 |
Pharmavite LLC establishes direct-to-consumer sales company |
None |
| 2009-09-05 |
Sinovac to purchase H1N1 vaccine for the national stockpiling plan |
None |
| 2009-09-05 |
Flu vaccinations now available at all 22 Target Clinic locations |
None |
| 2009-09-05 |
FDA notifies PDUFA action date for Cell Therapeutics' NDA for pixantrone |
None |
| 2009-09-05 |
Spectrum's ZEVALIN expanded label receives FDA approval for treating non-Hodgkin’s Lymphoma |
None |
| 2009-09-05 |
Discovery of two antibodies could move AIDS vaccine development forward |
None |
| 2009-09-05 |
Clinical trial of Cerebroprotein Hydrolysate for Injection completes |
4 |
| 2009-09-04 |
Target Clinics in Maryland start selling seasonal flu vaccinations |
None |
| 2009-09-04 |
New protein fragments identified for anthrax vaccine development |
5 |
| 2009-09-04 |
Shire receives FDA approval for INTUNIV extended release tablets |
None |
| 2009-09-04 |
Takeda receives FDA response regarding NDA for fixed-dose combination of alogliptin and ACTOS |
2 |
| 2009-09-04 |
Competition results in wide approval of Rev Vac safety syringe |
None |
| 2009-09-04 |
Research and Markets offers new report on antihypertensive market |
1 |
| 2009-09-04 |
Drive to collect unused prescription drugs starts on October 3 |
None |
| 2009-09-04 |
Filing and review of belatacept's license application accepted by the FDA |
None |
| 2009-09-04 |
rPA anthrax vaccine and its Valortim anthrax anti-toxin program data presented |
None |
| 2009-09-04 |
Reportlinker's market research report on plant-derived drugs |
None |
| 2009-09-04 |
Phase III clinical trial results of XIAFLEX published in a journal |
None |
| 2009-09-04 |
FDA review on postmarketing studies for approved drugs and biologics |
None |
| 2009-09-04 |
Research and Markets' report on authorized generics analysis |
None |
| 2009-09-04 |
Reportlinker provides an evaluation of the advanced wound care market in the U.S. |
None |
| 2009-09-04 |
FDA approves new xTAG Cystic Fibrosis 39 Kit v2 from Luminex |
None |
| 2009-09-04 |
Department of Health's guidance on swine flu vaccination leaves local health chiefs confused |
None |
| 2009-09-04 |
Shire's INTUNIV (Guanfacine) approved by the FDA for treatment of Attention-Deficit/Hyperactivity Disorder |
None |
| 2009-09-04 |
Giant Eagle offers generic prescription antibiotics for free at its in-store pharmacies |
None |
| 2009-09-04 |
Lawsuits filed against Johnson & Johnson, Ortho-McNeil Pharmaceutical and Walgreen |
3.7 |
| 2009-09-04 |
Sodium chloride for treating head lice |
None |
| 2009-09-04 |
Acticoat Flex dressings with NUCRYST's SILCRYST nanocrystalline silver coatings launched in Europe |
5 |
| 2009-09-04 |
SFDA approves production license for Sinovac's H1N1 vaccine |
None |
| 2009-09-04 |
ERT celebrates a significant milestone: Completes 150Th QT clinical Trial |
None |
| 2009-09-04 |
Acurox's New Drug Application discussed with the FDA |
None |
| 2009-09-04 |
IND for Cytopia's CYT387 clears the FDA review |
None |
| 2009-09-03 |
Two new antibodies for targeting HIV virus discovered |
4 |
| 2009-09-03 |
H1N1 vaccine to cost countries $2.50 - $20 per dose |
None |
| 2009-09-03 |
Updated Blue Spoon Consulting briefing note available for web download |
None |
| 2009-09-03 |
Endo Pharmaceuticals launches VALSTAR for treating recurrent carcinoma in situ bladder tumors |
3.3 |
| 2009-09-03 |
China Aoxing submits an NDA to the China SFDA for its Codeine Phosphate |
None |
| 2009-09-03 |
China Sky One Medical submits application to perform clinical trials for two new generic drugs |
None |
| 2009-09-03 |
Criminal pricing of Merck’s HIV/AIDS drug Isentress challenged by the AIDS Healthcare Foundation |
5 |
| 2009-09-03 |
Ethical Alternative Products launches the OmniFlex joint support formula |
None |
| 2009-09-03 |
MarketsandMarkets publishes report on global biosimilars market |
None |
| 2009-09-03 |
SAFLUTAN launched in United Kingdom and Spain |
None |
| 2009-09-03 |
Sheller, P.C helps to settle the largest whistleblower complaint |
None |
| 2009-09-03 |
Ten of ChemBridge's screening libraries available through CDD database |
None |
| 2009-09-03 |
Celgene to collaborate with PTC on advancing drug discovery efforts |
None |
| 2009-09-03 |
Pfizer finalizes settlement agreement with U.S. DOJ regarding past promotional practices |
None |
| 2009-09-03 |
P2Y2 to be included in the intellectual property sale auction |
None |
| 2009-09-03 |
Pfizer pleads guilty of defrauding Medicare, Medicaid and other government-funded health care programs |
None |
| 2009-09-03 |
Two 2008 drug approval reports highlight Ceplene benefits |
None |
| 2009-09-03 |
MarketsandMarkets offers new report on global anti-counterfeit market for food and pharmaceuticals |
None |
| 2009-09-03 |
ODAC calls for randomized study of Vion's Onrigin injection for treatment of the elderly AML patients |
None |
| 2009-09-03 |
New Marketing Authorization Application for Rhucin submitted to the EMEA by Pharming |
4.5 |
| 2009-09-03 |
FDA extends review period for Endo Pharmaceuticals' testosterone undecanoate |
None |
| 2009-09-03 |
Merck's SAFLUTAN launched in the UK and Spain |
4.5 |
| 2009-09-03 |
MIPI to sub-license the Onalta brand 90-Y edotreotide radiotherapeutic |
None |
| 2009-09-03 |
Gloucester’s romidepsin recommended for approval by the FDA Oncologic Drug Advisory Committee |
None |
| 2009-09-03 |
Sinovac Biotech signs marketing agreement with Boryung Pharmaceutical Company |
None |
| 2009-09-03 |
Clinical trial results of sumatriptan published in a journal |
1 |
| 2009-09-03 |
Millennium's sNDA to be reviewed by the FDA |
None |
| 2009-09-03 |
Pfizer to pay $301 million as setlement for illegal off-label promotion of Geodon |
None |
| 2009-09-03 |
FDA's Oncologic Drugs Advisory Committee votes in favor of FOLOTYN NDA |
None |
| 2009-09-03 |
Bextra qui tam lawsuit leads to Pfizer's whopping $2.3 billion settlement |
None |
| 2009-09-03 |
Intendis GmbH forges agreement with SkinMedica to acquire two prescription dermatology products |
None |
| 2009-09-03 |
Hong Kong's healthcare workers to refuse H1N1 vaccine, says study |
5 |
| 2009-09-03 |
Pfizer agrees to a $1.2 billion fine for fraudulent drug marketing practices |
None |
| 2009-09-02 |
BioMS Medical update on dirucotide development |
None |
| 2009-09-02 |
FDA approves Meda's ASTEPRO Nasal Spray |
None |
| 2009-09-02 |
NCI to announce the results of follow-up study of PharmaGap's lead drug GAP-107B8 |
5 |
| 2009-09-02 |
Cavit Sciences and McCoy form an agreement to finalize their merger |
None |
| 2009-09-02 |
Combination of LIVALO and itraconazole drugs shows no adverse reactions |
None |
| 2009-09-02 |
Validus chooses Ranbaxy to market an authorized generic version of Rocaltrol in the US |
None |
| 2009-09-02 |
Ferguson OTC Center of Excellence launched to address increase use of OTC drugs |
None |
| 2009-09-02 |
FDA approves Astepro nasal spray 0.15% for the treatment of the symptoms of seasonal allergies |
None |
| 2009-09-02 |
Corticosteroid and antiviral agent combination proves to be beneficial for treating Bell Palsy |
None |
| 2009-09-02 |
ACTICOAT Flex 3 and ACTICOAT Flex 7 launched in Europe |
None |
| 2009-09-02 |
Knopp Neurosciences to accelerate the development of KNS-760704 in ALS, says CEO of Knopp |
None |
| 2009-09-02 |
Ono Pharmaceutical secures exclusive rights to develop and commercialize asimadoline in Japan |
None |
| 2009-09-02 |
Positive results from second pivotal phase III trial for Lodotra |
None |
| 2009-09-02 |
Study reveals that valsartan prevents cardiovascular events in high-risk hypertensive Japanese patients |
None |
| 2009-09-02 |
Actelion launches new 20 mcg/mL Ventavis formulation |
None |
| 2009-09-02 |
Nuvo Research's co-operative drug development project with Fraunhofer Institute for developing WF10 |
5 |
| 2009-09-02 |
Mylan's subsidiary launches levalbuterol inhalation solution used for treating bronchospasm |
None |
| 2009-09-02 |
Irbesartan drug minimizes heart failure complications in patients with atrial fibrillation |
None |
| 2009-09-02 |
NF-kappa B inhibitors protect against toxicity during radiation treatment |
None |
| 2009-09-01 |
Schering-Plough launches CLARITIN 12-Hour for non-drowsy relief from allergy symptoms |
None |
| 2009-09-01 |
Reportlinker offers a comprehensive report on the biotechnology market in Poland |
None |
| 2009-09-01 |
Medivir adds MIV-711 to bone-related disorder treatment candidate portfolio |
None |
| 2009-09-01 |
New report from Reportlinker provides data on the current and future value of clinical trials markets |
None |
| 2009-09-01 |
Bio-Matrix Scientific Group's new opportunities in cancer treatment and intellectual property discussed |
None |
| 2009-09-01 |
Thirty controlled-release drugs reviewed in new report by Research and Markets |
1 |
| 2009-09-01 |
Cimzia approved for treating adult patients with rheumatoid arthritis |
None |
| 2009-09-01 |
Cumberland Pharmaceuticals to discuss its recently approved FDA product at the UBS Conference |
None |
| 2009-09-01 |
Chemists design polymer-coated nanorods for drug manufacturers |
None |
| 2009-09-01 |
BioSyent's subsidiary BioSyent Pharma signs an exclusive product development agreement |
None |
| 2009-09-01 |
FDA approves Hospira's six new vial presentations of heparin |
None |
| 2009-09-01 |
OHSU study reveals that fluoroquinolones may cause double vision |
None |
| 2009-09-01 |
Fourth-quarter 2009 report on South Korea's pharmaceuticals and healthcare industry offered by Research and Markets |
None |